-
Mashup Score: 0PREVENT Cancer Preclinical Drug Development Program (PREVENT) - 1 year(s) ago
The PREVENT program provides a structure for the introduction of new agents, drugs and vaccines to inhibit, retard or reverse the cancer process. The program was designed to optimize translational opportunities from discovery to the clinic, and provide a mechanism to identify and study efficacy and pharmacodynamics biomarkers that will help in phase II trials to evaluate drug effects. | The…
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Identifying New Biomarkers to Detect Lung Cancer Earlier - 1 year(s) ago
Identifying New Biomarkers to Detect Lung Cancer Earlier
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#LungCancer, the leading cause of cancer deaths worldwide, is often diagnosed at an advanced stage when the chances for a cure are limited. Researchers are working to change that with a precision approach to early detection. Read more: https://t.co/MahJvMlOeu https://t.co/hIH6HcUbA4
-
-
Mashup Score: 0Funding Opportunities - 1 year(s) ago
This is a listing of Requests for Applications (RFA), Program Announcements (PA), and Notices specific to the group’s key programs. Standard submission dates apply for all listings, unless otherwise noted. Guidance For Investigators Planning to Submit a Program Project Grant (P01) NCI SBIR Contract Solicitation Digital Tools to Integrate Cancer Prevention Within Primary Care…
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Working in #CancerResearch and looking for your next #FundingOpportunity? Visit https://t.co/Q8djIIheSq to view our request for applications and program announcements. https://t.co/AXFyIKDA8v
-
-
Mashup Score: 0Grantsmanship Resources - 1 year(s) ago
Information for investigators relevant to preparation, submission, and tracking of grant applications and peer review. |
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Check out the NCI Division of Cancer Prevention website for guidance on submitting your next grant application – we are here to help you. https://t.co/gMRo5C1lTl https://t.co/iUtcazwjCQ
-
-
Mashup Score: 0
There are two main types of endometrial cancer and the aggressive nonendometrioid type is causing more deaths.
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Over 90% of uterine cancers begin in the endometrium, the tissue lining the uterus. There are two main subtypes of #EndometrialCancer, endometrioid and nonendometrioid, and the subtypes are showing different trends, a recent @theNCI-led study found. https://t.co/TO4Yp6ymsN https://t.co/eRMu2bZI1o
-
-
Mashup Score: 1Research Highlights: Recently Published Studies on Compounds from Foods and Their Effect of Cancer Risk Measures - 1 year(s) ago
Cruciferous vegetable extracts shown to detoxify tobacco exposure.
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
These #ResearchHighlights explore recently published studies on compounds from foods and their effect on #CancerRisk measures. Read more: https://t.co/uSPiGpHtKu https://t.co/lBEOVEqQ58
-
-
Mashup Score: 0HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network - 1 year(s) ago
Background **FLASH** Funding Opportunity Announcement for Clinical Sites to join the ‘CASCADE’ Network Through the Funding Opportunity Announcement (FOA) RFA-CA-22-051, NCI will be soliciting applications from institutions/organizations to participate as international and domestic Clinical Sites for the HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network. | Seeks to conduct pragmatic…
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Last year, @theNCI supported a new initiative, the HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network, which seeks to optimize #CervicalCancer screening, management, and precancer treatment. Learn more about CASCADE: https://t.co/9Me0vc6MiW https://t.co/xHm8F74C6A
-
-
Mashup Score: 0Trials Test Vaccines for Prevention or Delay of Cancers Associated with Lynch Syndrome - 1 year(s) ago
Researchers have recruited the first vaccine candidates to one of two new prevention trials that seek to immunize hig
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Researchers have recruited the first vaccine candidates to one of two new prevention trials that seek to immunize high-risk individuals against cancers associated with Lynch syndrome, the most common cause of hereditary #ColorectalCancer. Read more: https://t.co/5yCsdtCUFW https://t.co/rRuFMr828Y
-
-
Mashup Score: 4Trials Test Vaccines for Prevention or Delay of Cancers Associated with Lynch Syndrome - 1 year(s) ago
Researchers have recruited the first vaccine candidates to one of two new prevention trials that seek to immunize hig
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Trials have begun to test vaccines for the prevention or delay of cancers associated with #LynchSyndrome, the most common cause of hereditary #ColorectalCancer. https://t.co/22vemarJyg @NCIprevention
-
-
Mashup Score: 0
Research Highlights: Learning More about How Breast Cancer Progresses
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In a recent study of #BreastCancer progression, scientists mapped structural and functional patterns inside breast tissue that may help distinguish between preinvasive and invasive disease. Read the latest research on breast cancer progression: https://t.co/8Y2SEwJ2c0 https://t.co/s2I3BAdxJq
-
The PREVENT program is a peer-reviewed agent development program designed to support preclinical development of interventions and biomarkers for #CancerPrevention and interception towards clinical trials. The next deadline to apply is Monday, July 10. https://t.co/vb90ZiRQ7U https://t.co/b2qiQUpatr